The estimated Net Worth of Capital Iv, Lp Aisling Capi... is at least 53.7 百万$ dollars as of 15 July 2019. Capital Capi owns over 2,500,000 units of Sunesis Pharmaceuticals Inc stock worth over 53,732,000$ and over the last 5 years Capital sold SNSS stock worth over 0$.
Capital has made over 1 trades of the Sunesis Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Capital bought 2,500,000 units of SNSS stock worth 1,500,000$ on 15 July 2019.
The largest trade Capital's ever made was buying 2,500,000 units of Sunesis Pharmaceuticals Inc stock on 15 July 2019 worth over 1,500,000$. On average, Capital trades about 2,500,000 units every 0 days since 2019. As of 15 July 2019 Capital still owns at least 10,100,000 units of Sunesis Pharmaceuticals Inc stock.
You can see the complete history of Capital Capi stock trades at the bottom of the page.
Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over 89,557,714$ worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth 84,730,221$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of 14,060,191$. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth 1,980$.
Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: